Your browser doesn't support javascript.
loading
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1).
Chen, Yunxin; Gopalakrishnan, Sathish Kumar; Ooi, Melissa; Sultana, Rehena; Lim, Li Hui; Grigoropoulos, Nicholas; Ong, Shin Yeu; Xu, Mingge; Chng, Wee Joo; Goh, Yeow Tee; Nagarajan, Chandramouli.
Affiliation
  • Chen Y; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Gopalakrishnan SK; SingHealth Duke-NUS Blood Cancer Center, Singapore, Singapore.
  • Ooi M; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Sultana R; Department of Haematology, Health Sciences North, Sudbury, ON, Canada.
  • Lim LH; Department of Haematology, National University Hospital, Singapore, Singapore.
  • Grigoropoulos N; Centre for Quantitative Medicine, DUKE-NUS Medical School, Singapore, Singapore.
  • Ong SY; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Xu M; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Chng WJ; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Goh YT; SingHealth Duke-NUS Blood Cancer Center, Singapore, Singapore.
  • Nagarajan C; Department of Haematology, National University Hospital, Singapore, Singapore.
Blood Cancer J ; 11(9): 150, 2021 09 03.
Article in En | MEDLINE | ID: mdl-34480015
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Cyclophosphamide / Multiple Myeloma Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2021 Type: Article Affiliation country: Singapore
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Dexamethasone / Antineoplastic Combined Chemotherapy Protocols / Cyclophosphamide / Multiple Myeloma Type of study: Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Cancer J Year: 2021 Type: Article Affiliation country: Singapore